ThromboGenics (THR) - BEL20
			2 mensagens
			|Página 1 de 1
		
	
ThromboGenics (THR) - BEL20
A ThromboGenics passará a estar incluída no BEL20, a partir de 18 de Março.
			
				Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Biotechnology
Business Summary
ThromboGenics specializes in the research and development of bio-therapeutic products for treating cardiovascular diseases, ophthalmic disorders, and cancers. Net sales break down by source of income as follows:
- sales of licenses (96.9%);
- royalties (1.8%);
- other (1.3%).
4-traders.com
Editado pela última vez por C0rr3i4 em 19/2/2013 19:53, num total de 2 vezes.
					
				
			C0rr3i4
"Compound interest is the 8th wonder of the world."
(Albert Einstein)
		"Compound interest is the 8th wonder of the world."
(Albert Einstein)
			2 mensagens
			|Página 1 de 1
		
	
Quem está ligado:
		Utilizadores a ver este Fórum: Abade19, Akinfiev, caganixo7, cmsbarros, Goya777, Kury Yozo, m-m, malakas, maturidade, MR32, nunorpsilva, O Magriço, PAULOJOAO, paulopereira.pp36.pp, SerCyc, Shimazaki_2, Simplório, trilhos2006, TTM62 e 148 visitantes
	
                                                
                                                
                                                